Matthew Stern, MD
University of Pennsylvania, Philadelphia, PA USA
Webinar Topic: The Era of Preclinical Detection Is Upon Us: Will it Change Clinical Practice?
Webinar Description: The potential to identify individuals at high risk for Parkinson’s disease is close at hand, using a variety of biomarker, clinical, genetic and imaging screening paradigms. How should clinicians approach high risk individuals when there is still no proven neuroprotective prescription?
- Understand strategies for the preclinical detection of PD
- Consider novel approaches to individuals at high risk for developing PD
Target Audience: Neurologists and ancillary healthcare providers interested in Parkinson’s disease
This lecture will be made available for on-demand viewing starting on November 18, 2020.
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME). The International Parkinson and Movement Disorder Society is accredited by the ACCME to provide continuing medical education for physicians.
Credit Designation Statement:
The International Parkinson and Movement Disorder Society designates this activity for a maximum of 0.50 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation.
Participants must complete an evaluation for each session they attend to receive continuing medical education credit. Your chosen session(s) must be attended in their entirety. Partial credit for individual sessions is not available.
Content Validity Statement:
All recommendations involving clinical medicine in MDS activities are based on evidence that is accepted within the profession of medicine as adequate justification for their indications and contraindications in the case of patients. All scientific research referred to, reported or used in CME in support or justification of a patient care recommendations conforms to the generally accepted standards of experimental design, data collection and analysis. Activities that promote recommendations, treatment or manners of practicing medicine not within the definition of CME or are knowing to have risks or dangers that outweigh the benefits or are knowing to be ineffective in the treatment of patients do not constitute valid CME.
Disclosure of Financial Relationships:
All individuals in control of content for this webinar are required to disclose all relevant financial relationships with commercial interests as defined by the ACCME. Disclosure information is available here.